Phase II study of mitomycin C plus 5-fluorouracil in patients with refractory ovarian cancer. 1994

I Peláez, and R López, and I Palacio, and Y Fernández, and E Estrada, and E Esteban, and J M Buesa, and A J Lacave

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D005260 Female Females
D005472 Fluorouracil A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. 5-FU,5-FU Lederle,5-FU Medac,5-Fluorouracil,5-Fluorouracil-Biosyn,5-HU Hexal,5FU,Adrucil,Carac,Efudex,Efudix,Fluoro-Uracile ICN,Fluoroplex,Fluorouracil Mononitrate,Fluorouracil Monopotassium Salt,Fluorouracil Monosodium Salt,Fluorouracil Potassium Salt,Fluorouracil-GRY,Fluorouracile Dakota,Fluorouracilo Ferrer Far,Fluoruracil,Fluracedyl,Flurodex,Haemato-FU,Neofluor,Onkofluor,Ribofluor,5 FU Lederle,5 FU Medac,5 Fluorouracil,5 Fluorouracil Biosyn,5 HU Hexal,Dakota, Fluorouracile,Fluoro Uracile ICN,Fluorouracil GRY,Haemato FU
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy
D016685 Mitomycin An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis. Mitomycin C,Ametycine,Mitocin-C,Mitomycin-C,Mutamycin,NSC-26980,Mitocin C,MitocinC,NSC 26980,NSC26980

Related Publications

I Peláez, and R López, and I Palacio, and Y Fernández, and E Estrada, and E Esteban, and J M Buesa, and A J Lacave
September 1995, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society,
I Peláez, and R López, and I Palacio, and Y Fernández, and E Estrada, and E Esteban, and J M Buesa, and A J Lacave
January 1992, European journal of gynaecological oncology,
I Peláez, and R López, and I Palacio, and Y Fernández, and E Estrada, and E Esteban, and J M Buesa, and A J Lacave
May 2007, Onkologie,
I Peláez, and R López, and I Palacio, and Y Fernández, and E Estrada, and E Esteban, and J M Buesa, and A J Lacave
June 1988, Seminars in oncology,
I Peláez, and R López, and I Palacio, and Y Fernández, and E Estrada, and E Esteban, and J M Buesa, and A J Lacave
June 2001, American journal of clinical oncology,
I Peláez, and R López, and I Palacio, and Y Fernández, and E Estrada, and E Esteban, and J M Buesa, and A J Lacave
January 1982, Cancer,
I Peláez, and R López, and I Palacio, and Y Fernández, and E Estrada, and E Esteban, and J M Buesa, and A J Lacave
June 2003, Journal of chemotherapy (Florence, Italy),
I Peláez, and R López, and I Palacio, and Y Fernández, and E Estrada, and E Esteban, and J M Buesa, and A J Lacave
January 2001, Oncology,
I Peláez, and R López, and I Palacio, and Y Fernández, and E Estrada, and E Esteban, and J M Buesa, and A J Lacave
January 2011, Tumori,
I Peláez, and R López, and I Palacio, and Y Fernández, and E Estrada, and E Esteban, and J M Buesa, and A J Lacave
May 1997, Der Urologe. Ausg. A,
Copied contents to your clipboard!